A clinical trial presented by Lembcke Perez Prieto in 2013 [87] evaluated a human tyrosinase anti-melanoma vaccine, Oncept® (Merial Limited, Athens, GA, USA), in 10 horses bearing melanomas; the vaccine presented tumor burden reductions and was apparently safe and well tolerated in horses. This evidence concerns the gene TYR and melanoma.